Joseph A. Pinto

Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

Justin M. Balko, Jennifer M. Giltnane, Kai Wang et al. · Cancer Discovery · 2013 · 467 citations · Full text

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 280 citations · Full text

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

Justin M. Balko, Rebecca S. Cook, David Vaught et al. · Nature Medicine · 2012 · 255 citations · Full text

Breast Oncology, Residual Breast Cancers, Medicine +10

Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?

Joseph A. Pinto, Carlos Vallejos, Luis E. Raez et al. · ESMO Open · 2018 · 164 citations · Full text

Breast Cancer Classification According to Immunohistochemistry Markers: Subtypes and Association With Clinicopathologic Variables in a Peruvian Hospital Database

Carlos Vallejos, Henry Gómez, Wilder R. Cruz et al. · Clinical Breast Cancer · 2010 · 163 citations

Breast Oncology, Medicine, Pathology +9